Danaher (DHR) News Today: Latest Market and Industry Updates

224.01
0.3800
0.17 %
Daily range
Weekly range
  • Mira Kyivska
  • 07.10.2026
Danaher to launch AI-powered research lab for drug discovery in 2027
Danaher is preparing to expand its use of artificial intelligence in life sciences with an autonomous research lab designed to speed up drug discovery and development. The facility is expected to ...
  • Ciaran Ryan
  • 05.10.2026
What's behind Danaher's latest stock surge?
Danaher Corporation (DHR) climbed 3.06% as investors responded to accelerating Q2 revenue growth and the ongoing transition to new leadership. The bullish move is supported by the stock trading ...
  • Darina Pashchenko
  • 03.09.2026
Club portfolio exits highlight profit-taking discipline and stock-picking risks in 2026
Volatile trading in 2026 is pushing stock investors to balance profit protection with rapid shifts in geopolitics, monetary policy and sector leadership. Against that backdrop, the Club says its ...
  • Sholanke Dele
  • 20.08.2026
Why is Danaher stock up today? Earnings, CEO change and key drivers in focus
Danaher (DHR) stock is trading at $218.85, up 3.47% for the day with momentum carrying it above its key moving averages. The current price action is positioned well ...
  • Ciaran Ryan
  • 14.07.2026
UK finance ministry defends fiscal stability ahead of likely leadership transition
Britain is preparing for a likely change at the top of government this month as Chancellor Rachel Reeves argues that stable public finances remain central to Labour's economic approach. Her ...
  • Ciaran Ryan
  • 09.07.2026
Sony Bank wins preliminary U.S. approval for stablecoin trust unit
Sony Financial Group is moving deeper into digital assets as its banking arm prepares a regulated entry into the U.S. stablecoin market. The plan centers on a new trust bank subsidiary backed by ...
  • Ashutosh Sureka
  • 25.06.2026
What triggered Danaher shares' latest price surge
Danaher Corporation (DHR) jumped 3.11% after completing its $9.9 billion acquisition of Masimo Corporation and securing FDA clearance for Masimo's AI-enabled opioid-induced respiratory depression ...
  • Sholanke Dele
  • 19.06.2026
Danaher stock trades flat as revenue rises 3.7 percent year-over-year
Danaher Corporation (DHR) stock is trading at $177.48, down 0.16% for the day. The price remains below its key moving averages, reflecting ongoing downward momentum ...